Extraordinarily Elevated CA19-9 in Benign Conditions: a Case Report and Review of the Literature

Overview

Journal Tumori

Publisher Sage Publications

Specialty Oncology

Date 2002 Jan 5

PMID 11765186

Citations 26

Authors

M Akdogan

N Sasmaz

B Kayhan

I Biyikoglu

S Disibeyaz

B Sahin

Affiliations

Soon will be listed here.

Abstract

Carbohydrate antigen CA19-9 is commonly used in the diagnosis of pancreatic and biliary malignancies. However, increases in its level in benign conditions such as acute cholangitis or pancreatitis have also been reported. A 79-year-old woman presented with cholangitis and a pancreatic pseudocyst while showing elevation of CA19-9 up to 35,500 U/mL. The patient was adequately treated and at two months' follow-up the CA19-9 level had returned to normal.

Citing Articles

Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 Levels.

Law J, Trieu H, Kaleka G, Turkiewicz J, Palmer S, Lee J Cancers (Basel). 2023; 15(6).

PMID: 36980609 PMC: 10046349. DOI: 10.3390/cancers15061723.

Looks can be Deceiving: A Case Report on the Clinical Value of CA 19-9 in Obstructive Jaundice.

Giron F, Alcantar D Cureus. 2020; 12(1):e6637.

PMID: 32064210 PMC: 7011587. DOI: 10.7759/cureus.6637.

Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.

Park J, Choi Y, Namkung J, Yi S, Kim H, Yu J Oncotarget. 2017; 8(54):93117-93130.

PMID: 29190982 PMC: 5696248. DOI: 10.18632/oncotarget.21861.

The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.

Kuzu U, Odemis B, Suna N, Yildiz H, Parlak E, Disibeyaz S J Gastrointest Cancer. 2015; 47(1):8-14.

PMID: 26537791 DOI: 10.1007/s12029-015-9777-1.

Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker.

Lin M, Huang J, Yu H Int J Clin Exp Med. 2014; 7(3):744-50.

PMID: 24753772 PMC: 3992417.